Status
212%
financed
Share
Funding data (05 August 2025)
Raised
GBP
63,758,466.00
Min. Goal
GBP
30,000,000.00
Min. investment
GBP
4,726.00
Details
Country
United Kingdom
Type
Equity
End date
05 August 2025
(311 days)
investors
160
Description
“Digostics is transforming diabetes care with GTT@home — the world’s first at-home oral glucose tolerance test (OGTT). Our CE-marked digital platform delivers home-based diabetes screening, supporting earlier detection and relieving healthcare system pressures. Adopted by NHS Trusts and approved in multiple markets, Digostics is redefining diabetes detection.”